2018-2025 Receptor Tyrosine Protein Kinase Targeted Drugs Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

March 2018 | 123 pages | ID: 2F09E1FAE3AQEN
QYResearch

Abstracts

SUMMARY

This report studies the Receptor Tyrosine Protein Kinase Targeted Drugs market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Receptor Tyrosine Protein Kinase Targeted Drugs market by product type and application/end industries.

The global Receptor Tyrosine Protein Kinase Targeted Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Receptor Tyrosine Protein Kinase Targeted Drugs.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Receptor Tyrosine Protein Kinase Targeted Drugs in these regions, from 2013 to 2025 (forecast), covering

• United States
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

The major players in global and United States market, including

• Aslan Pharmaceuticals Pte Ltd
• Boehringer Ingelheim GmbH
• GamaMabs Pharma SA
• Hanmi Pharmaceuticals Co Ltd
• Jiangsu Kanion Pharmaceutical Co Ltd
• Minerva Neurosciences Inc
• Pfizer Inc
• Puma Biotechnology Inc
• Shanghai Fosun Pharmaceutical (Group) Co Ltd
• XuanZhu Pharma Co Ltd
• Zensun (Shanghai) Sci & Tech Co Ltd

On the basis of product, the market is primarily split into

• Afatinib Dimaleate
• Dacomitinib
• Neratinib
• Neucardin
• Others

On the basis on the end users/application, this report covers

• Oncology
• Cardiovascular
• Central Nervous System
• Others

Contents

2018-2025 RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS REPORT ON GLOBAL AND UNITED STATES MARKET, STATUS AND FORECAST, BY PLAYERS, TYPES AND APPLICATIONS

1 METHODOLOGY AND DATA SOURCE

1.1 Methodology/Research Approach
  1.1.1 Research Programs/Design
  1.1.2 Market Size Estimation
  1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
  1.2.1 Secondary Sources
  1.2.2 Primary Sources
1.3 Disclaimer

2 RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS MARKET OVERVIEW

2.1 Receptor Tyrosine Protein Kinase Targeted Drugs Product Overview
2.2 Receptor Tyrosine Protein Kinase Targeted Drugs Market Segment by Type
  2.2.1 Afatinib Dimaleate
  2.2.2 Dacomitinib
  2.2.3 Neratinib
  2.2.4 Neucardin
  2.2.5 Others
2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Product Segment by Type
  2.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
  2.3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Market Share (%) by Type (2013-2018)
  2.3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Market Share (%) by Type (2013-2018)
  2.3.4 Global Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Pcs) by Type (2013-2018)
2.4 United States Receptor Tyrosine Protein Kinase Targeted Drugs Product Segment by Type
  2.4.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
  2.4.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Market Share by Type (2013-2018)
  2.4.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
  2.4.4 United States Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Pcs) by Type (2013-2018)

3 RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS APPLICATION/END USERS

3.1 Receptor Tyrosine Protein Kinase Targeted Drugs Segment by Application/End Users
  3.1.1 Oncology
  3.1.2 Cardiovascular
  3.1.3 Central Nervous System
  3.1.4 Others
3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Product Segment by Application
  3.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Product Segment by Application
  3.3.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.3.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Market Share (%) by Application (2013-2018)

4 RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS MARKET STATUS AND OUTLOOK BY REGIONS

4.1 Global Market Status and Outlook by Regions
  4.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and CAGR by Regions (2013, 2017 and 2025)
  4.1.2 North America
  4.1.3 Asia-Pacific
  4.1.4 Europe
  4.1.5 South America
  4.1.6 Middle East and Africa
  4.1.7 United States
4.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Revenue by Regions
  4.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
  4.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
  4.2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.4 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.5 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.6 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.7 South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
  4.2.8 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.9 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

5 GLOBAL RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

5.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Market Share by Players (2013-2018)
5.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Average Price (USD/Pcs) by Players (2013-2018)
5.4 Global Top Players Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base Distribution, Sales Area, Product Types
5.5 Receptor Tyrosine Protein Kinase Targeted Drugs Market Competitive Situation and Trends
  5.5.1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Concentration Rate
  5.5.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share (%) of Top 3 and Top 5 Players
  5.5.3 Mergers & Acquisitions, Expansion

6 UNITED STATES RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

6.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Market Share by Players (2013-2018)
6.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Average Price (USD/Pcs) by Players (2013-2018)
6.4 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Share (%) of Top 3 and Top 5 Players

7 RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

7.1 Aslan Pharmaceuticals Pte Ltd
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Boehringer Ingelheim GmbH
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.2.4 Main Business/Business Overview
7.3 GamaMabs Pharma SA
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.3.4 Main Business/Business Overview
7.4 Hanmi Pharmaceuticals Co Ltd
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.4.4 Main Business/Business Overview
7.5 Jiangsu Kanion Pharmaceutical Co Ltd
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.5.4 Main Business/Business Overview
7.6 Minerva Neurosciences Inc
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Pfizer Inc
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Puma Biotechnology Inc
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.8.4 Main Business/Business Overview
7.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.9.4 Main Business/Business Overview
7.10 XuanZhu Pharma Co Ltd
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.10.4 Main Business/Business Overview
7.11 Zensun (Shanghai) Sci & Tech Co Ltd

8 RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS MANUFACTURING COST, INDUSTRIAL CHAIN AND DOWNSTREAM BUYERS

8.1 Receptor Tyrosine Protein Kinase Targeted Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
8.4 Downstream Buyers in United States

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS AND MARKET EFFECT FACTORS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
  9.3.1 Economic/Political Environmental Change
  9.3.2 Downstream Demand Change
  9.3.3 Technology Progress in Related Industry
  9.3.4 Substitutes Threat

10 GLOBAL RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS MARKET FORECAST

10.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue Forecast (2018-2025)
  10.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.1.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast
  10.2.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.2.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Forecast by Regions
  10.3.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.3 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.4 South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.5 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.4 Receptor Tyrosine Protein Kinase Targeted Drugs Forecast by Type
  10.4.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
  10.4.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Receptor Tyrosine Protein Kinase Targeted Drugs Forecast by Application
  10.5.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) Forecast by Application (2018-2025)
  10.5.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Receptor Tyrosine Protein Kinase Targeted Drugs Product Picture
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of Afatinib Dimaleate
Table Major Players of Afatinib Dimaleate
Figure Global Afatinib Dimaleate Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Dacomitinib
Table Major Players of Dacomitinib
Figure Global Dacomitinib Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Neratinib
Table Major Players of Neratinib
Figure Global Neratinib Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Neucardin
Table Major Players of Neucardin
Figure Global Neucardin Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Pcs) and Growth Rate (%)(2013-2018)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2013-2018)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share (%) by Type (2013-2018)
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share (%) by Type (2013-2018)
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share (%) by Type in 2017
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share (%) by Type (2013-2018)
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share (%) by Type
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Pcs) by Type (2013-2018)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2013-2018)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share (%) by Type (2013-2018)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share (%) by Type (2013-2018)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share (%) by Type in 2017
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) by Type (2013-2018)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share (%) by Type (2013-2018)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share (%) by Type
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Pcs) by Type (2013-2018)
Figure Oncology Examples
Figure Cardiovascular Examples
Figure Central Nervous System Examples
Figure Others Examples
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) Comparison by Application (2013-2025)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Application (2013-2018)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share (%) by Application (2013-2018)
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share (%) by Application (2013-2018)
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share (%) by Application in 2017
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) Comparison by Application (2013-2025)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Application (2013-2018)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share (%) by Application (2013-2018)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share (%) by Application (2013-2018)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share (%) by Application in 2017
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Regions (2013-2018)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share (%) by Regions (2013-2018)
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share (%) by Regions
Figure 2017 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share (%) in Global Market
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share (%) by Regions
Figure 2017 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share (%) in Global Market
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) of Key Players (2013-2018)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share (%) by Players (2013-2018)
Figure 2017 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share (%) by Players
Figure 2018 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share (%) by Players
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) by Players (2013-2018)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share (%) by Players (2013-2018)
Table 2017 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share (%) by Players
Table 2018 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share (%) by Players
Table Global Market Receptor Tyrosine Protein Kinase Targeted Drugs Average Price (USD/Pcs) by Players (2013-2018)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Top Players Manufacturing Base Distribution and Sales Area
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Top Players Product Category
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share (%) of Top 3 Players
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share (%) of Top 5 Players
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Players (2013-2018)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share (%) by Players
Figure 2018 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share (%) by Players
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) by Players (2013-2018)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share (%) by Players
Table 2018 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share (%) by Players
Table United States Market Receptor Tyrosine Protein Kinase Targeted Drugs Average Price (USD/Pcs) by Players (2013-2018)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Share (%) of Top 3 Players
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Share (%) of Top 5 Players
Table Aslan Pharmaceuticals Pte Ltd Basic Information List
Table Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2013-2018)
Figure Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Global Market Share (%)(2013-2018)
Figure Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Global Market Share (%)(2013-2018)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales Global Market Share (%)(2013-2018)
Figure Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Global Market Share (%)(2013-2018)
Table GamaMabs Pharma SA Basic Information List
Table GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2013-2018)
Figure GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Global Market Share (%)(2013-2018)
Figure GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Global Market Share (%)(2013-2018)
Table Hanmi Pharmaceuticals Co Ltd Basic Information List
Table Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2013-2018)
Figure Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Global Market Share (%)(2013-2018)
Figure Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Global Market Share (%)(2013-2018)
Table Jiangsu Kanion Pharmaceutical Co Ltd Basic Information List
Table Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2013-2018)
Figure Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Global Market Share (%)(2013-2018)
Figure Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Global Market Share (%)(2013-2018)
Table Minerva Neurosciences Inc Basic Information List
Table Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2013-2018)
Figure Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales Global Market Share (%)(2013-2018)
Figure Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Global Market Share (%)(2013-2018)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2013-2018)
Figure Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales Global Market Share (%)(2013-2018)
Figure Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Global Market Share (%)(2013-2018)
Table Puma Biotechnology Inc Basic Information List
Table Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2013-2018)
Figure Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales Global Market Share (%)(2013-2018)
Figure Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Global Market Share (%)(2013-2018)
Table Shanghai Fosun Pharmaceutical (Group) Co Ltd Basic Information List
Table Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2013-2018)
Figure Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Global Market Share (%)(2013-2018)
Figure Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Global Market Share (%)(2013-2018)
Table XuanZhu Pharma Co Ltd Basic Information List
Table XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2013-2018)
Figure XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Global Market Share (%)(2013-2018)
Figure XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Global Market Share (%)(2013-2018)
Table Zensun (Shanghai) Sci & Tech Co Ltd Basic Information List
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Receptor Tyrosine Protein Kinase Targeted Drugs
Figure Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
Table Major Buyers of Receptor Tyrosine Protein Kinase Targeted Drugs
Table Distributors/Traders List
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States Receptor Tyrosine Protein Kinase Targeted DrugsReceptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) Forecast by Regions (2018-2025)
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure South America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Application (2018-2025)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) Forecast by Application (2018-2025)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Application (2018-2025)